Carpmaels & Ransford LLP is pleased to announce that Emma Maiden and Clarissa Luxton have been promoted to Senior Associate positions, effective from 1st January 2026.

Both Emma and Clarissa have worked at the firm from the beginning of their careers as patent attorneys. Emma works in the Life Sciences group and has expertise in a broad range of technical subject matter, with a particular focus on therapeutic antibodies, as well as CAR-T therapies and their surrounding technologies. Emma has experience in strategic management of large global patent portfolios for commercial antibody products, and particularly enjoys working with clients on creative strategies for follow-on protection of these products. At the EPO, Emma regularly advises clients across all stages of patent prosecution. She has experience attacking and defending patents in multi-party proceedings at the EPO relating to commercial products (both first instance and appeal) and is involved in multiple Europe-wide litigation projects. Emma uses her experience in these contentious matters to inform prosecution strategies for robust protection.

Clarissa is also a member of the Life Sciences Group, working across a broad range of subject matter in the pharmaceuticals sector, including NCEs, medical uses, formulations and polymorphs. She regularly advises on European and global patent prosecution, managing several complex worldwide patent portfolios and developing and coordinating central prosecution strategies to bring these applications through to grant. Clarissa has been involved in numerous European Patent Office opposition and appeal proceedings and national litigation relating to patents and SPCs covering marketed products. She has also recently been involved in litigation before the UPC, where she has applied her existing expertise in this new forum.

Hugh Goodfellow, Senior Partner, comments: “Congratulations to Emma and Clarissa on their well-deserved promotions. We are pleased to recognise their significant contributions to the firm and the important role they will play in strengthening our Life Sciences practice group, reflecting our continued commitment to developing home-grown talent at Carpmaels & Ransford.”